| Not Yet Recruiting | SMYD3-Driven Metabolic Rewiring in Colorectal Liver Metastases NCT07497789 | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | — |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without I NCT07284849 | Incyte Corporation | Phase 3 |
| Recruiting | A Prospective, Safety, and Efficacy Clinical Trial of Pressurized Intraperitoneal Aerosol Therapy for Peritone NCT07349043 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 1 |
| Recruiting | Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in O NCT07254910 | University of Oklahoma | N/A |
| Recruiting | Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer NCT07478731 | Hong Qiu | Phase 2 |
| Not Yet Recruiting | Improving Rates of Diagnostic Colonoscopy in Native Americans NCT07115875 | University of Oklahoma | N/A |
| Recruiting | Identification of New Non-invasive, Predictive, and Diagnostic Biomarkers for Colorectal Cancer NCT07153458 | Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | — |
| Recruiting | A Study of GFH375 Combined With Cetuximab or Chemotherapy in Participants With Solid Tumors Harboring KRAS G12 NCT07259590 | Genfleet Therapeutics (Shanghai) Inc. | Phase 1 / Phase 2 |
| Not Yet Recruiting | A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced NCT07198321 | Genfleet Therapeutics (Shanghai) Inc. | Phase 1 / Phase 2 |
| Recruiting | A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors NCT07085091 | ALX Oncology Inc. | Phase 1 |
| Not Yet Recruiting | PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer NCT07133750 | Biotheus Inc. | Phase 2 |
| Recruiting | An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorecta NCT07033026 | NGM Biopharmaceuticals, Inc | Phase 2 |
| Recruiting | A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Me NCT07376707 | Hefei TG ImmunoPharma Co., Ltd. | Phase 1 |
| Not Yet Recruiting | A Study of DCTY1102 Injection in Patients With Advanced Solid Tumors NCT07014878 | Beijing DCTY Biotech Co.,Ltd. | Phase 1 |
| Not Yet Recruiting | An Exploratory Clinical Study Evaluating the Efficacy and Safety of Tunlametinib Combined With Fruquintinib in NCT06985316 | Liu Huang | N/A |
| Recruiting | Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer NCT06675513 | Wondercel Biotech (ShenZhen) | EARLY_Phase 1 |
| Not Yet Recruiting | A Prospective Study to Evaluate the Performance of a Real-time System in the Estimation of Colorectal Polyp Si NCT06957015 | Chinese University of Hong Kong | N/A |
| Recruiting | BBO-11818 in Adult Subjects With KRAS Mutant Cancer NCT06917079 | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | Phase 1 |
| Recruiting | A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations NCT06835569 | Alterome Therapeutics, Inc. | Phase 1 |
| Recruiting | A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants Wit NCT06720987 | Kumquat Biosciences Inc. | Phase 1 |
| Recruiting | An Exploratory Study on Gene Methylation Detection of Colorectal Cancer NCT07033156 | Zhejiang Provincial People's Hospital | — |
| Recruiting | Universal CAR-T Cells (REVO-UWD-01) for Metastatic Colorectal Cancer NCT06653010 | Wondercel Biotech (ShenZhen) | EARLY_Phase 1 |
| Recruiting | Validation of High-Throughput Large-Format Tissue Preprocessing for Lung and Colorectal Cancer NCT07239063 | Nanfang Hospital, Southern Medical University | — |
| Recruiting | cfDNA 5mC/5hmC Biomarkers to Predict Chemotherapy Response in Metastatic Colorectal Cancer NCT07224815 | City of Hope Medical Center | — |
| Recruiting | Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC NCT07224841 | City of Hope Medical Center | — |
| Not Yet Recruiting | Interactive Telehealth Intervention to Increase Longitudinal Adherence to Repeat Faecal Immunochemical Test Sc NCT06261008 | Chinese University of Hong Kong | N/A |
| Not Yet Recruiting | Effectiveness of Using Mobile Health Technology in Colorectal Cancer Screening Uptake NCT06192862 | Chinese University of Hong Kong | N/A |
| Recruiting | Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors NCT05856981 | Sairopa B.V. | Phase 1 |
| Active Not Recruiting | Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors NCT05651022 | Indaptus Therapeutics, Inc | Phase 1 / Phase 2 |
| Completed | Safety and Efficacy of Neoantigen-Based Personalized Immunotherapy as Consolidation Therapy After Standard Adj NCT07504484 | Ying Yuan, MD | Phase 1 |
| Terminated | Study of Ruxolitinib in Colorectal Cancer Patients NCT02119676 | Incyte Corporation | Phase 2 |